纳微科技：公司关注微球在药物制剂领域的应用机会 有计划采取与药企合作研发方式推进项目转化

Group 1 - The company focuses on the core business of biopharmaceutical separation and purification while exploring opportunities for microspheres in drug formulation [1] - The company plans to collaborate with pharmaceutical companies for research and development to advance project conversion [1] - The drug application project conversion cycle is long and will not contribute to the company's current operating performance [1]